Hygeia Healthcare Holdings Co., Ltd. (HK:6078)
:6078
Want to see HK:6078 full AI Analyst Report?
Top Page
Hygeia Healthcare Holdings Co., Ltd.
(6078)
Select Model
Select Model
Rating:56Neutral
Price Target:
HK$12.00
▼(-5.44% Downside)
Action:Reiterated
Date:05/02/26
The score is held up by solid revenue growth, manageable leverage, and improving 2025 cash flow, but it is weighed down by the sharp 2025 profitability deterioration. Technically, the stock is in a clear downtrend with weak momentum, and valuation is stretched with a high P/E and no dividend yield support.
Positive Factors
Manageable leverage
Stable, below‑unit leverage and an improving debt-to-equity ratio provide financial flexibility for a hospital group. Manageable borrowing lets Hygeia fund incremental bed capacity and equipment without excessive interest burden, supporting durable operations and capital investments over 2–6 months and beyond.
Negative Factors
Sharp profitability deterioration
A sudden, large net-margin drop compresses earnings power and suggests either rising unit costs, pricing pressure, or one-off losses. Sustained margin weakness would reduce reinvestment capacity and ROE, undermining long-term growth funding and operational resilience absent structural fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
Stable, below‑unit leverage and an improving debt-to-equity ratio provide financial flexibility for a hospital group. Manageable borrowing lets Hygeia fund incremental bed capacity and equipment without excessive interest burden, supporting durable operations and capital investments over 2–6 months and beyond.
Read all positive factors
Hygeia Healthcare Holdings Co., Ltd. (6078) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$6.49B
Dividend YieldN/A
Average Volume (3M)7.15M
Price to Earnings (P/E)41.9
Beta (1Y)1.51
Revenue Growth-9.81%
EPS Growth-72.56%
CountryHK
Employees8,169
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.07
Shares Outstanding618,499,000
10 Day Avg. Volume3,556,037
30 Day Avg. Volume7,151,771
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)1.02
Price to Sales (P/S)1.72
P/FCF Ratio14.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$19.68Price Target Upside55.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.82
Revenue Forecast (FY)HK$4.35B
Hygeia Healthcare Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offer oncology healthcare services, such as tumor screening and g...
How the Company Makes Money
Hygeia Healthcare Holdings Co., Ltd. primarily makes money by charging for medical services delivered at its hospitals. Key revenue streams generally include (1) inpatient services (e.g., hospital stays, surgeries, procedures, nursing care, medici...
Hygeia Healthcare Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
66
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.01B | 4.45B | 4.08B | 3.20B | 2.32B |
| Gross Profit | 1.02B | 1.31B | 1.29B | 1.02B | 744.66M |
| EBITDA | 951.82M | 999.10M | 1.11B | 868.43M | 623.67M |
| Net Income | 164.53M | 598.26M | 682.93M | 476.78M | 441.46M |
Balance Sheet | |||||
| Total Assets | 10.67B | 10.93B | 10.73B | 7.24B | 6.69B |
| Cash, Cash Equivalents and Short-Term Investments | 741.02M | 651.59M | 755.89M | 884.71M | 1.10B |
| Total Debt | 2.45B | 2.79B | 2.72B | 1.29B | 1.23B |
| Total Liabilities | 3.88B | 4.25B | 4.48B | 2.30B | 2.21B |
| Stockholders Equity | 6.77B | 6.65B | 6.23B | 4.93B | 4.46B |
Cash Flow | |||||
| Free Cash Flow | 466.39M | 92.02M | -157.98M | 92.26M | -236.84M |
| Operating Cash Flow | 949.98M | 707.13M | 782.84M | 685.38M | 426.25M |
| Investing Cash Flow | -412.62M | -671.09M | -2.86B | -372.06M | -850.85M |
| Financing Cash Flow | -476.79M | -216.56M | 1.78B | -154.21M | 754.50M |
Hygeia Healthcare Holdings Co., Ltd. Technical Analysis
Negative
12.69
Price Trends
11.86
Negative
12.62
Negative
13.34
Negative
Market Momentum
-0.28
Positive
26.13
Positive
11.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6078, the sentiment is Negative. The current price of 12.69 is above the 20-day moving average (MA) of 11.62, above the 50-day MA of 11.86, and below the 200-day MA of 13.34, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 26.13 is Positive, neither overbought nor oversold. The STOCH value of 11.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6078.
Hygeia Healthcare Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$6.35B | 17.47 | 15.36% | 2.61% | 7.60% | 20.01% | |
71 Outperform | HK$662.10M | 2.28 | 6.66% | 9.14% | -1.48% | 549.60% | |
66 Neutral | HK$954.19M | 5.21 | 18.05% | 4.37% | -4.23% | 3.95% | |
62 Neutral | HK$4.97B | 17.83 | 33.08% | 1.97% | 16.70% | 38.98% | |
56 Neutral | HK$6.49B | 41.92 | 0.62% | ― | -9.81% | -72.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$6.19B | 16.86 | -10.66% | 2.38% | -5.73% | -442.94% |
* Healthcare Sector Average
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
10.57
-4.93
-31.81%
HK:1526
Rici Healthcare Holdings Ltd.
0.60
-0.51
-45.95%
HK:1951
Jinxin Fertility Group Ltd.
2.30
-0.58
-20.14%
HK:2273
Gushengtang Holdings Limited
27.10
-6.23
-18.69%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
19.79
2.10
11.87%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.98
0.23
13.14%
Hygeia Healthcare Holdings Co., Ltd. Corporate Events
Hygeia Healthcare Profit Slumps on Goodwill Hit but Cash Flow and Buybacks Strengthen
Mar 30, 2026
Hygeia Healthcare reported 2025 revenue of RMB4,008.8 million, down 9.8% year on year, with net profit dropping 73.0% to RMB161.5 million, mainly due to a RMB283.3 million goodwill impairment on Etern Group Ltd. Despite weaker earnings, non-IFRS a...
Hygeia Healthcare Schedules Board Meeting to Approve 2025 Annual Results
Mar 18, 2026
Hygeia Healthcare Holdings Co., Limited has scheduled a board meeting for March 30, 2026, to review and approve the annual results for the year ended December 31, 2025. The board will also consider the publication of these results and discuss whet...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.